A patient-based model of RNA mis-splicing uncovers treatment targets in Parkinson's disease.
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
09 09 2020
09 09 2020
Historique:
received:
06
06
2018
revised:
24
01
2020
accepted:
22
06
2020
entrez:
10
9
2020
pubmed:
11
9
2020
medline:
24
6
2021
Statut:
ppublish
Résumé
Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder with monogenic forms representing prototypes of the underlying molecular pathology and reproducing to variable degrees the sporadic forms of the disease. Using a patient-based in vitro model of
Identifiants
pubmed: 32908004
pii: 12/560/eaau3960
doi: 10.1126/scitranslmed.aau3960
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.